M. Look

发表

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance

J. Foekens, M. Look, E. Diamandis, 2002, British Journal of Cancer.

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours

N. Brünner, J. Foekens, J. Klijn, 2001, British Journal of Cancer.

The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.

J. Foekens, J. Klijn, K. Wingerden, 1997, British Journal of Cancer.

Relationship of p53, uPA, pS2, EGF-R, and c-ERBB2, with response to systemic treatment in recurrent breast cancer patient

J. Foekens, J. Klijn, M. M. Gelder, 1997 .

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

S. Sleijfer, J. Foekens, A. Sieuwerts, 2010, Breast Cancer Research and Treatment.

Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection

Kurt Stockinger, T. Sauerbruch, U. Spengler, 1997, European Journal of Clinical Nutrition.

Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease.

M. Altfeld, J. Rockstroh, T. Sauerbruch, 2000, AIDS research and human retroviruses.

Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial.

T. Sauerbruch, U. Spengler, M. Look, 1999, Antiviral research.

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

J. Foekens, J. Klijn, M. Look, 1999, British Journal of Cancer.

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

J. Foekens, J. Klijn, C. Sweep, 1999, British Journal of Cancer.

Clinical relevance of the urokinase plasminogen activator system in breast cancer

J. Foekens, M. Look, M. Look, 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer

J. Foekens, J. Klijn, M. M. Gelder, 1999, British Journal of Cancer.

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.

J. Foekens, J. Klijn, B. Thirion, 1994, British Journal of Cancer.

Vitamin E status in patients with liver cirrhosis: normal or deficient?

Kurt Stockinger, M. von Falkenhausen, T. Sauerbruch, 1999, Metabolism: clinical and experimental.

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients

J. Foekens, J. Klijn, C. Sweep, 1999, British Journal of Cancer.

Decrease of elevated N,N-dimethylglycine and N-methylglycine in human immunodeficiency virus infection during short-term highly active antiretroviral therapy.

T. Sauerbruch, J. Rockstroh, M. Look, 2001, Metabolism: clinical and experimental.

Intravenous Treatment of Hyperhomocysteinemia in Patients on Chronic Hemodialysis—A Pilot Study

T. Sauerbruch, M. Look, R. Woitas, 2004, Renal failure.

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

S. Sleijfer, J. Martens, J. Foekens, 2011, Breast Cancer Research and Treatment.

High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.

T. H. van der Kwast, J. Foekens, J. Klijn, 2001, Cancer research.

Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.

J. Foekens, J. Klijn, S. van der Flier, 2000, Journal of the National Cancer Institute.

Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease

J. Foekens, J. Klijn, M. Look, 2003, British Journal of Cancer.

High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer.

S. Sleijfer, J. Martens, J. Foekens, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.

J. Foekens, J. Klijn, S. Romain, 2001, Cancer research.

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.

J. Foekens, J. Klijn, E. Berns, 1998, British Journal of Cancer.

Non-operative management in a case of spontaneous splenic rupture in infectious mononucleosis.

T. Sauerbruch, M. Look, A. Hirner, 1995, Zeitschrift fur Gastroenterologie.

Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase?

J. Rockstroh, T. Sauerbruch, U. Spengler, 2000, Scandinavian journal of gastroenterology.

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

J. Foekens, J. Klijn, M. Look, 2001, British Journal of Cancer.

The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study Group.

J. Foekens, M. Look, M. Timmermans, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.